Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype

被引:155
作者
Meijer, M. J. W. [1 ]
Mieremet-Ooms, M. A. C. [1 ]
van der Zon, A. M. [1 ]
van Duijn, W. [1 ]
van Hogezand, R. A. [1 ]
Sier, C. F. M. [1 ]
Hommes, D. W. [1 ]
Lamers, C. B. H. W. [1 ]
Verspaget, H. W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Gastroenterol Hepatol, NL-2300 RC Leiden, Netherlands
关键词
fibrosis; fistulae; IBD; MMP; TIMP;
D O I
10.1016/j.dld.2007.05.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and objective. Matrix metalloproteinases are associated with matrix turnover in both physiological and pathological conditions. We postulate an association between aberrant matrix metalloproteinases proteolytic activity and the intestinal tissue destruction, seen in patients with Crohn's disease and/or ulcerative colitis. Materials and methods. Surgically resected inflamed and non-inflamed ileum and colon with/without extensive fibrosis from 122 Crohn's disease, 20 ulcerative colitis and 62 control patients were homogenized. Protein levels of matrix metalloproteinases and tissue inhibitor of metalloproteinases were measured by enzyme-linked immunosorbent assays (ELISA), while matrix metalloproteinases and myeloperoxidase activity were measured by specific activity assays. Results. Expression of total levels of matrix metalloproteinases-1, -2, -3 and -9 relative to tissue inhibitor of metalloproteinases-1 and -2 was increased in inflamed inflammatory bowel disease compared to non-inflamed inflammatory bowel disease and control intestinal mucosa. Also, net matrix metalloproteinases-1, -2, -3 and -9 activity in inflamed inflammatory bowel disease was increased, with similar expression profiles in Crohn's disease and ulcerative colitis. Within inflamed inflammatory bowel disease, a close correlation of matrix metalloproteinases with myeloperoxidase was observed. The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases was similar in inflamed Crohn's disease tissue with or without extensive fibrosis and not related to fistulizing disease. Conclusions. We have shown increased net matrix metalloproteinases activity in intestinal inflammatory bowel disease tissue, likely to contribute to the tissue damage and remodelling seen in inflammatory bowel disease. (C) 2007 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 45 条
[1]
BACKSTROM JR, 1995, J NEUROCHEM, V64, P1312
[2]
Matrix metalloproteinase levels are elevated in inflammatory bowel disease [J].
Baugh, MD ;
Perry, MJ ;
Hollander, AP ;
Davies, DR ;
Cross, SS ;
Lobo, AJ ;
Taylor, CJ ;
Evans, GS .
GASTROENTEROLOGY, 1999, 117 (04) :814-822
[3]
Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer [J].
Bister, VO ;
Salmela, MT ;
Karjalainen-Lindsberg, ML ;
Uria, J ;
Lohi, J ;
Puolakkainen, P ;
Lopez-Otin, C ;
Saarialho-Kere, U .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (04) :653-661
[4]
Determination of gelatinase-A (MMP-2) activity using a novel immunocapture assay [J].
Capper, SJ ;
Verheijen, J ;
Smith, L ;
Sully, M ;
Visser, H ;
Hanemaaijer, R .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :487-490
[5]
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat [J].
Corbel, M ;
Caulet-Maugendre, S ;
Germain, N ;
Molet, S ;
Lagente, V ;
Boichot, E .
JOURNAL OF PATHOLOGY, 2001, 193 (04) :538-545
[6]
Ulcerative colitis [J].
Farrell, RJ ;
Peppercorn, MA .
LANCET, 2002, 359 (9303) :331-340
[7]
FRIDMAN R, 1995, CANCER RES, V55, P2548
[8]
Expression of matrix metalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases [J].
Gao, Q ;
Meijer, MJW ;
Kubben, FJGM ;
Sier, CFM ;
Kruidenier, L ;
van Duijn, W ;
van den Berg, M ;
van Hogezand, RA ;
Lamers, CBHW ;
Verspaget, HW .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (08) :584-592
[9]
Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease [J].
Gao, Qiang ;
Meijer, Martin J. W. ;
Schlueter, Ulrike G. ;
van Hogezand, Ruud A. ;
van der Zon, Johanna M. ;
van den Berg, Marlies ;
van Duijn, Wim ;
Lamers, Cornelis B. H. W. ;
Verspaget, Hein W. .
INFLAMMATORY BOWEL DISEASES, 2007, 13 (06) :693-702
[10]
COLLAGEN CONTENT AND TYPES IN THE INTESTINAL STRICTURES OF CROHNS-DISEASE [J].
GRAHAM, MF ;
DIEGELMANN, RF ;
ELSON, CO ;
LINDBLAD, WJ ;
GOTSCHALK, N ;
GAY, S ;
GAY, R .
GASTROENTEROLOGY, 1988, 94 (02) :257-265